Polynovo (ASX:PNV) Other Gross PPE : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Polynovo Other Gross PPE?

Polynovo's Other Gross PPE for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Polynovo's quarterly Other Gross PPE increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$21.02 Mil) but then declined from Jun. 2023 (A$21.02 Mil) to Dec. 2023 (A$0.00 Mil).

Polynovo's annual Other Gross PPE increased from Jun. 2021 (A$4.74 Mil) to Jun. 2022 (A$13.89 Mil) and increased from Jun. 2022 (A$13.89 Mil) to Jun. 2023 (A$21.02 Mil).

Polynovo Other Gross PPE Historical Data

The historical data trend for Polynovo's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Other Gross PPE Chart

Polynovo Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Gross PPE

Get a 7-Day Free Trial

2.00

4.73

4.74

13.89

21.02

Polynovo Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															-	13.89	-	21.02	-

Polynovo Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Polynovo (ASX:PNV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (ASX:PNV) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

CALZF:USA MFJ:Germany

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (ASX:PNV) Headlines

No Headlines